Cardiovascular magnetic resonance (CMR) imaging may help physicians make decisions about which patients with suspected cardiac sarcoidosis require an implantable cardioverter-defibrillator (ICD) to ...
PROFID EHRA, the first clinical trial seeking to challenge routine implantation of defibrillators in heart attack survivors with heart failure has just been launched. The European Society of ...
Looking at a large cohort of patients undergoing various types of open heart surgery, investigators have provided contemporary data that can be used to inform patients about the risks of cardiac ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A subcutaneous implantable cardioverter defibrillator was safe and effective in a higher-risk ...
The benefit of an implantable cardioverter–defibrillator (ICD) in patients with symptomatic systolic heart failure caused by coronary artery disease has been well documented. However, the evidence for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results